MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

An European-Canadian multinational evaluation of access to care in Parkinson disease: a patient perspective

M. van Munster, E. Crighton, A. Sánchez-Ferro, J. Ferreira, R. Bouça, E. Ruzicka, D. Pedrosa, D. Grimes, T. Mestre (Marburg, Germany)

Meeting: 2023 International Congress

Abstract Number: 1975

Keywords: Parkinson’s

Category: Other

Objective: To provide a multi-national perspective of people with Parkinson disease (PwPD) on access to healthcare and the impact of the COVID-19 pandemic on those perspectives.

Background: PwPD may develop different healthcare needs during their illness. The COVID-19 pandemic brought additional challenges to access to care. To date, research on how PwPD perceive their health care is largely lacking. It is also unclear how COVID-19 pandemic impacted these perceptions.

Method: We conducted an online survey for PwPD in Canada, Germany, Portugal, Spain, and the Czech Republic advertised through national patient associations in the third and fourth quarter of 2021. Results are presented descriptively and univariate associations were tested using Chi Square. A p-value <0.05 was deemed statistically significant.

Results: In total, there were 1,104 respondents. Overall, 701 participants reported some sort of difficulty in access to PD care before the COVID-19 pandemic (63,5%). Overall, there were no significant change in those perceptions as a result of the pandemic. Before the COVID-19 pandemic, greater perceived difficulties in access to PD care was associated with lesser satisfaction with overall PD care (OR: 2.88, 95% CI: 2.22-3.75), postponing a treatment because of costs (OR: 4.22, 95%CI:2.9 – 6.1), and being a female (OR:1.42 95% CI:1:06 -1.89).

Conclusion: COVID-19 pandemic appears to have had a smaller than expected impact on perceptions of health care in PwPDs. There are individual factors that are significantly associated perception of access to PD care in Canada and Europe. When planning new care delivery strategies, it is important to consider these factors in order to identify groups at risk for increased difficulty in accessing care.

To cite this abstract in AMA style:

M. van Munster, E. Crighton, A. Sánchez-Ferro, J. Ferreira, R. Bouça, E. Ruzicka, D. Pedrosa, D. Grimes, T. Mestre. An European-Canadian multinational evaluation of access to care in Parkinson disease: a patient perspective [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/an-european-canadian-multinational-evaluation-of-access-to-care-in-parkinson-disease-a-patient-perspective/. Accessed May 10, 2025.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/an-european-canadian-multinational-evaluation-of-access-to-care-in-parkinson-disease-a-patient-perspective/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley